LLMpediaThe first transparent, open encyclopedia generated by LLMs

AHA Scientific Sessions

Generated by GPT-5-mini
Note: This article was automatically generated by a large language model (LLM) from purely parametric knowledge (no retrieval). It may contain inaccuracies or hallucinations. This encyclopedia is part of a research project currently under review.
Article Genealogy
Parent: Asensus Surgical Hop 4
Expansion Funnel Raw 86 → Dedup 0 → NER 0 → Enqueued 0
1. Extracted86
2. After dedup0 (None)
3. After NER0 ()
4. Enqueued0 ()
AHA Scientific Sessions
NameAHA Scientific Sessions
CaptionAnnual meeting of the American Heart Association
StatusActive
GenreMedical conference
DateVaries (usually November)
FrequencyAnnual
VenueVarious (convention centers)
LocationUnited States
Years active1924–present
OrganizerAmerican Heart Association

AHA Scientific Sessions The AHA Scientific Sessions is the American Heart Association's flagship annual meeting that convenes clinicians, researchers, and policymakers to present cardiovascular research, clinical trials, and guidelines. It brings together specialists from institutions such as Mayo Clinic, Cleveland Clinic, Johns Hopkins Hospital, Massachusetts General Hospital, and Stanford University alongside representatives from organizations like National Institutes of Health, Food and Drug Administration, Centers for Disease Control and Prevention, World Health Organization, and European Society of Cardiology. The meeting often features late-breaking clinical trials, guideline sessions, and award lectures that influence practice in cardiology, cardiovascular surgery, and related fields.

History

The meeting traces institutional roots to early 20th-century gatherings linked to American Heart Association activities and annual conventions that paralleled developments at Harvard Medical School, Columbia University, University of Pennsylvania, University of Michigan, and University of California, San Francisco. Throughout the 20th century the Sessions adapted to wartime and peacetime shifts influenced by events like World War II, the postwar expansion of National Institutes of Health funding, and the rise of subspecialties cultivated at centers such as Brigham and Women's Hospital and Mount Sinai Hospital. Landmark eras included the emergence of randomized controlled trials inspired by methods from Oxford University and statisticians tied to London School of Hygiene and Tropical Medicine, and the translational surge tied to work at University of Oxford, Karolinska Institute, and Imperial College London. The modern conference expanded under leadership connected to figures who trained at Yale School of Medicine, Duke University School of Medicine, Vanderbilt University Medical Center, and University of Chicago Medicine.

Organization and Format

Organized by the American Heart Association, the Sessions are planned by program committees with liaisons from entities like American College of Cardiology, Society for Cardiovascular Angiography and Interventions, Heart Rhythm Society, American College of Physicians, and American Thoracic Society. Venues have included large convention centers in cities such as Chicago, Philadelphia, Los Angeles, New Orleans, Dallas, and Boston. Typical formats mirror structures used by European Society of Cardiology congresses and American College of Cardiology annual meetings: plenary sessions, parallel symposia, poster halls, industry-sponsored satellite sessions, and late-breaking trial sessions. Registration tiers accommodate attendees from institutions like Kaiser Permanente, Mount Sinai Health System, Northwestern Memorial Hospital, and NYU Langone Health as well as trainees from programs at Mayo Clinic Alix School of Medicine, Icahn School of Medicine at Mount Sinai, and Perelman School of Medicine at the University of Pennsylvania.

Scientific Program and Sessions

The scientific program features basic science tracks from laboratories affiliated with Broad Institute, Salk Institute, Cold Spring Harbor Laboratory, and Howard Hughes Medical Institute investigators; translational sessions showcasing work from University of Cambridge, Johns Hopkins University, and University of Toronto; and clinical trial presentations by teams at Brigham and Women's Hospital, Cleveland Clinic Foundation, and Massachusetts General Hospital Heart Center. Session types include late-breaking clinical trials, guideline updates, clinical practice sessions, cardiovascular imaging symposia tied to Society of Cardiovascular Computed Tomography and American Society of Echocardiography, electrophysiology tracks linked to Heart Rhythm Society, pediatric cardiology forums with contributors from Children's Hospital of Philadelphia and Boston Children's Hospital, and sessions on health disparities with involvement from Robert Wood Johnson Foundation and Kaiser Family Foundation representatives.

Notable Presentations and Trials

The Sessions historically premiered landmark trial results and guideline-relevant data, often rivaling releases at European Society of Cardiology meetings and American College of Cardiology conferences. Notable trials presented have involved research teams associated with Framingham Heart Study, INTERHEART study, SPRINT trial, and investigations influenced by methodology from Randomized Clinical Trial pioneers at Oxford Clinical Trials Research Unit. Investigators from Duke Clinical Research Institute, Vanderbilt University Medical Center, Emory University School of Medicine, University of California, San Diego, and University of Pittsburgh Medical Center have frequently delivered presentations that shaped practice in interventional cardiology, heart failure, arrhythmia management, and preventive cardiology.

Attendance and Impact

Attendance routinely includes researchers, clinicians, industry representatives from companies headquartered near Silicon Valley and Boston biotech clusters, guideline authors from American Heart Association councils, and public health stakeholders from Centers for Medicare & Medicaid Services and Agency for Healthcare Research and Quality. The conference influences citation activity, guideline revisions, and device approvals by regulators such as the Food and Drug Administration and informs payer decisions at organizations like Blue Cross Blue Shield Association and UnitedHealthcare. International delegations have come from institutions including Tokyo University Hospital, National University of Singapore, University of Sydney, University of Toronto, and Charité – Universitätsmedizin Berlin.

Awards and Recognitions

Sessions include presentation of honors and lectures named for leaders associated with institutions like American Heart Association founders, often paralleling awards given by European Society of Cardiology and American College of Cardiology. Recipients are drawn from faculty at Harvard Medical School, Stanford University School of Medicine, Columbia University Vagelos College of Physicians and Surgeons, Yale School of Medicine, and University of Oxford. Awards highlight contributions in cardiovascular research, clinical trials, epidemiology (linked to Framingham Heart Study), and mentorship with laureates often subsequently elected to bodies such as the National Academy of Medicine and awarded honors by Lasker Foundation and Royal Society.

Category:Medical conferences